Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prajnan Das

Showing results (181-190 of 324) with videos related to

Pageof 33
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2025
Survival Benefit of Palliative Oophorectomy for Patients With Ovarian Metastasis From Baseline Metastatic Gastric AdenocarcinomaMatheus Sewastjanow-Silva, Lianchun Xiao, Ahmed Abdelhakeem, et al.
Oncotarget|November 7, 2014
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canalCathy Eng, George J Chang, Y Nancy You, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane, Cathy Eng, Barry W Feig, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2018
Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matchingNaruhiko Ikoma, Prajnan Das, Wayne Hofstetter, et al.
Practical Radiation Oncology|October 28, 2023
Daily Vaginal Dilator Use During Radiation for Women With Squamous Cell Carcinoma of the Anus: Vaginal Wall Dosimetry and Patient-Reported Sexual FunctionAngelica Arzola, Enoch Chang, Michael K Rooney, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinomaBrian De, Ethan B Ludmir, Craig A Messick, et al.
Clinical and Translational Radiation Oncology|September 14, 2019
Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignanciesShalini Moningi, Ethan B Ludmir, Praveen Polamraju, et al.
Cancer|June 29, 2023
Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer researchAlexander D Sherry, Kelsey L Corrigan, Ramez Kouzy, et al.
Cancers|January 27, 2021
Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy ResponseAhmed A Abdelhakeem, Xuemei Wang, Rebecca E Waters, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal CancerSuzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Pageof 33

Showing results (181-190 of 324) with videos related to

Sort By:
Pageof 33
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2025
Survival Benefit of Palliative Oophorectomy for Patients With Ovarian Metastasis From Baseline Metastatic Gastric AdenocarcinomaMatheus Sewastjanow-Silva, Lianchun Xiao, Ahmed Abdelhakeem, et al.
Oncotarget|November 7, 2014
The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canalCathy Eng, George J Chang, Y Nancy You, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancerChristopher H Crane, Cathy Eng, Barry W Feig, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 7, 2018
Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matchingNaruhiko Ikoma, Prajnan Das, Wayne Hofstetter, et al.
Practical Radiation Oncology|October 28, 2023
Daily Vaginal Dilator Use During Radiation for Women With Squamous Cell Carcinoma of the Anus: Vaginal Wall Dosimetry and Patient-Reported Sexual FunctionAngelica Arzola, Enoch Chang, Michael K Rooney, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinomaBrian De, Ethan B Ludmir, Craig A Messick, et al.
Clinical and Translational Radiation Oncology|September 14, 2019
Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignanciesShalini Moningi, Ethan B Ludmir, Praveen Polamraju, et al.
Cancer|June 29, 2023
Prevalence, trends, and characteristics of trials investigating local therapy in contemporary phase 3 clinical cancer researchAlexander D Sherry, Kelsey L Corrigan, Ramez Kouzy, et al.
Cancers|January 27, 2021
Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy ResponseAhmed A Abdelhakeem, Xuemei Wang, Rebecca E Waters, et al.
International Journal of Radiation Oncology, Biology, Physics|July 10, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal CancerSuzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Pageof 33